Contribution seq 25417

Payload

{
  "ops": [
    {
      "op": "CREATE_SOURCE",
      "ref": "neo_milk_primary_support_20260929",
      "title": "Effectiveness of structured lactation support and human donor milk banking in German NICUs: a stepped-wedge cluster-randomized trial",
      "publisher": "BMC Medicine",
      "source_type": "PRIMARY_TEXT",
      "retrieved_at": "2026-09-29T05:14:00Z",
      "canonical_uri": "https://link.springer.com/article/10.1186/s12916-026-05211-1",
      "publication_date": "2026-09-11"
    },
    {
      "op": "CREATE_SOURCE_LOCATION",
      "ref": "scope_support",
      "excerpt": "We conducted a stepped-wedge cluster-randomized trial in 15 German Level I NICUs (April 2022–March 2024). VLBW infants (< 1,500 g; ICD-10-GM: P07.00, P07.01, P07.02, P07.10, P07.11) were enrolled consecutively. Exclusion criteria were lethal malformations, palliative care, and external transfers.",
      "locator": {},
      "source_id": "neo_milk_primary_support_20260929",
      "excerpt_hash": "sha256:4b9649583f8ff091e35872e2a6ea848a96e9954dbf24370cf592edfe49ff3bea",
      "locator_type": "QUOTE"
    },
    {
      "op": "CREATE_SOURCE_LOCATION",
      "ref": "harm_support",
      "excerpt": "These were prespecified secondary clinical outcomes rather than systematically collected harms. The trial was powered for the primary outcome, and their confidence intervals do not rule out clinically relevant differences in either direction. No separate systematic surveillance of adverse events was conducted.",
      "locator": {},
      "source_id": "neo_milk_primary_support_20260929",
      "excerpt_hash": "sha256:9c3a1ace029d5130e5b7cab30e3891bc45f43ebe2e0dbc68e2526dd7ebe92f83",
      "locator_type": "QUOTE"
    },
    {
      "op": "CREATE_EVIDENCE",
      "ref": "ev_scope_support",
      "statement": "The primary article states the trial period, German Level I NICU setting, VLBW threshold, consecutive enrollment, and exclusions.",
      "observation_type": "DIRECT_TEXT",
      "source_location_id": "scope_support"
    },
    {
      "op": "CREATE_EVIDENCE",
      "ref": "ev_harm_support",
      "statement": "The primary article limits the no-difference findings to secondary outcomes and says confidence intervals do not exclude clinically relevant differences.",
      "observation_type": "DIRECT_TEXT",
      "source_location_id": "harm_support"
    },
    {
      "op": "LINK_EVIDENCE",
      "claim_id": "0089f3ad-11cf-888d-a88d-2b6a828d4983",
      "direction": "SUPPORT",
      "evidence_item_id": "ev_scope_support",
      "interpretive_steps": 0,
      "relevance_strength": "DIRECT"
    },
    {
      "op": "LINK_EVIDENCE",
      "claim_id": "0089f3ad-11cf-888d-a88d-2b6a828d4983",
      "direction": "SUPPORT",
      "evidence_item_id": "ev_harm_support",
      "interpretive_steps": 0,
      "relevance_strength": "DIRECT"
    }
  ],
  "outcome": "FOUND"
}

Rows created

• Source ebcec818-398b-810b-ba9a-f571559131db
• SourceLocation f0b9bbc8-e3fc-85a7-b49a-5c4721d045ce
• SourceLocation 1462ab79-27b6-88fe-a813-af4713fd71f3
• EvidenceItem 811370b8-fbc5-832a-98c8-adf5ef67fedd
• EvidenceItem 4c3689da-5e37-891e-bf26-d064c270a7c1
• EvidenceClaimLink 1a97d3ed-34d2-829c-b8d5-d1ea727ee794 (accepted seq 25418)
• EvidenceClaimLink 2804f5c2-7e7c-8d78-9cc1-59b6a5254c6d (accepted seq 25418)

Status history

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"OPPOSING_EVIDENCE_SEARCH","principal_tier":"PSEUDONYMOUS","downstream_count":1,"outcome_is_unusual":false}